Sensitive NGF Methodology for Plasma Cell Detection
Corresponding Organization :
Other organizations : Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Centro de Investigación del Cáncer, Institut Català d'Oncologia, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Vall d'Hebron Hospital Universitari, Hospital Universitario de Canarias, Research Institute Hospital 12 de Octubre, Clinica Universidad de Navarra
Variable analysis
- Recently developed NGF methodology (Table S1)
- Detection of at least 20 aberrant plasma cells in a sample
- Hemodilution of bone marrow samples for NGF evaluation was assessed through the identification of a significant decrease in non-plasma cell populations: mast cells (CD117hi), erythroblasts (CD45−/sideward-scatter-lo) and B-cell precursors (CD19+/CD38hi/CD45lo)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!